Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kathrin Tan"'
Autor:
Kathrin Tan, Christian Jäger, Stefanie Geissler, Dagmar Schlenzig, Mirko Buchholz, Daniel Ramsbeck
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 38, Iss 1 (2023)
Targeting metalloproteinases has been in the focus of drug design for a long time. However, meprin α and β emerged as potential drug targets just recently and are linked to several diseases with different pathological background. Nevertheless, the
Externí odkaz:
https://doaj.org/article/6cf1ad89dd504526bad8c27cce359ded
Autor:
Mirko Buchholz, Christian Jäger, Stefanie Geissler, Daniel Ramsbeck, Kathrin Tan, Dagmar Schlenzig, Walter Stöcker, Hagen Körschgen
Publikováno v:
Chemmedchem
Astacin metalloproteinases, in particular meprins α and β, as well as ovastacin, are emerging drug targets. Drug‐discovery efforts have led to the development of the first potent and selective inhibitors in the last few years. However, the most r
Autor:
Hagen Körschgen, Christian Jäger, Kathrin Tan, Mirko Buchholz, Walter Stöcker, Daniel Ramsbeck
Despite huge progress in hormonal therapy and improved in vitro fertilization methods, the success rates in infertility treatment are still limited. A recently discovered mechanism revealed the interplay between the plasma protein fetuin-B and the co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b44f6a53d7d8a5134b19574b64aa8f5
https://doi.org/10.26434/chemrxiv.11306867
https://doi.org/10.26434/chemrxiv.11306867
Autor:
Stephan Schilling, Mirko Buchholz, Dagmar Schlenzig, Christian Jäger, Daniel Ramsbeck, Kathrin Tan
Publikováno v:
ChemMedChem. 13(16)
Metalloproteinases of the astacin family are drawing ever increasing attention as potential drug targets. However, knowledge regarding inhibitors thereof is limited in most cases. Crucial for the development of metalloprotease inhibitors is high sele